| Pui-yue Phan Iii, | |
|
10941 Olive Blvd, Creve Coeur, MO 63141-7740 | |
| (314) 997-0555 | |
| (314) 997-6422 |
| Full Name | Pui-yue Phan Iii |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 10941 Olive Blvd, Creve Coeur, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598047201 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2001030606 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pui-yue Phan Iii, 10941 Olive Blvd, Creve Coeur, MO 63141-7740 Ph: () - | Pui-yue Phan Iii, 10941 Olive Blvd, Creve Coeur, MO 63141-7740 Ph: (314) 997-0555 |
News Archive
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.
Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat diseases, today announced the presentation of Phase 1 clinical data for the company's lead therapeutic, LYR-210, for chronic rhinosinusitis, a debilitating disease caused by inflammation of the paranasal sinus tissues that affects approximately 27 million people, or 11% of the adult population in the U.S.
Researchers from the Moscow Institute of Physics and Technology have published a review on serial femtosecond crystallography, one of the most promising methods for analyzing the tertiary structure of proteins.
AMN Healthcare Services, Inc., the nation's leader and innovator in healthcare workforce solutions and staffing services, today announced the completion of the acquisition of Onward Healthcare, Locum Leaders and Medefis from OGH, LLC for a total purchase price of $82.5 million.
In a move likely to secure its place as a leading provider of medical radiation countermeasures, Humanetics Corporation today announced that it has secured exclusive worldwide licenses to two new treatments that provide short and long-term post-exposure protection from ionizing radiation acquired during a terrorist act, nuclear or radiological attack or accident, as part of cancer radiotherapy or even during routine diagnostic CT scans.
› Verified 2 days ago
Alex Gitman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10941 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-997-0555 | |
Randall Scott Piper, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12661 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-878-4413 | |
Dr. Stephanie Denise Ipock, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10941 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-997-0555 | |
Dr. Brittany Lynn Gisi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12661 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-878-4413 Fax: 314-878-8055 | |
Clayton Nelson Brown, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10420 Old Olive Street Rd, Suite 103, Creve Coeur, MO 63141 Phone: 314-736-5555 | |
Jeffrey Juang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10941 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-997-0555 | |
Dr. Zachary Nelson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11560 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-995-7128 |